Skip Navigation

International Immunology 2007 19(9):1103-1113; doi:10.1093/intimm/dxm081
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gardiner, A.
Right arrow Articles by Arneson, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gardiner, A.
Right arrow Articles by Arneson, L. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2007. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Conformation of MHC class II I-Ag7 is sensitive to the P9 anchor amino acid in bound peptide

Amy Gardiner1, Katherine A. Richards2, Andrea J. Sant2 and Lynne S. Arneson1

1 Department of Biology, American University, 4400 Massachusetts Avenue NW Washington, DC 20016, USA
2 David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, 601 Elmwood Avenue, Box 609, Rochester, NY 14642-8609, USA

Correspondence to: L. S. Arneson; E-mail: larneso{at}american.edu

Type I diabetes is a chronic autoimmune disease resulting in the destruction of insulin-producing ß cells in the pancreas. In humans, disease incidence is linked to expression of specific MHC class II alleles and in mice type I diabetes is associated with the class II allele I-Ag7. I-Ag7 contains a polymorphism that is shared by human class II alleles associated with the disease, at position 57 in the ß chain, in which aspartic acid is changed to a serine. The P9 pocket in the peptide-binding groove is in part shaped by ß57, and therefore the structure of this pocket is modified in I-Ag7. Using mAbs, we have previously determined that alternative conformations of I-Ag7 form in response to peptide binding. In this study, we have extended these findings by examining how peptides induce I-Ag7 molecules to adopt different conformations. By mutating the amino acid in the P9 position of either class II-associated invariant chain peptide (CLIP) or glutamic acid decarboxylase (GAD) 65 (207–220), we have determined that the chemical nature of the P9 anchor amino acid, either acidic or small hydrophobic, affects the overall conformation of the I-Ag7 class II molecule. T cell hybridomas specific for GAD 65 (207–220) in the context of I-Ag7 were also examined for recognition of I-Ag7 bound to GAD 65 (207–220), in which Glu217 in the P9 position was changed to alanine. We found that although some TCRs were able to recognize both peptides in the context of I-Ag7, and thus both class II conformations, approximately one-third of the T cells tested were not able to recognize the alternate class II conformation formed with the mutated peptide. These results indicate that the I-Ag7 conformations may affect functional activation of T cells, and thus may play a role in autoimmunity.

Keywords: autoimmunity, MHC, T cells


Transmitting editor: R. A. Flavell

Received 22 August 2006, accepted 19 June 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.